4//SEC Filing
Stelzer Laurie 4
Accession 0000950170-23-066143
CIK 0001636282other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 4:33 PM ET
Size
5.4 KB
Accession
0000950170-23-066143
Insider Transaction Report
Form 4
Stelzer Laurie
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-11-22+50,000→ 50,000 totalExercise: $10.39Exp: 2033-11-22→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 50,000 shares of the Issuer's common stock, which will vest and become exercisable in 36 equal monthly installments beginning on November 22, 2023 until such time as the option is 100% vested, subject to the Reporting Person's continuous service with the Issuer at each vesting date.
Documents
Issuer
Spyre Therapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001644348
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 4:33 PM ET
- Size
- 5.4 KB